A02-Limiting-Competition-under-SAT_ACC_-_Redacted.pdf

Control No: JA-19-08-0196

Version – February 2017

Memorandum for Record – Limiting Competition at or below the Simplified

Acquisition Threshold

1. Contracting Activity: The Contracting Activity responsible for this action is the U.S.

Army Medical Research Acquisition Activity (USAMRAA), 820 Chandler Street, Fort Detrick, MD 21702.

2. Description of Action: Approval is requested for a new sole source, Firm Fixed Priced (FFP) contract with Abbott Molecular, Inc for Walter Reed Army Institute Research (WRAIR) to provide preventative maintenance on a Government owned Abbott M2000 sp/rt System.. The contract will be fully funded and the estimated total value of the contract, including options, is $92,516.36.

New Requirement

Contract Vehicle: Purchase Order

Pricing/Contract Type: FFP

Funds: Operations & Maintenance, Army (OMA)

Name of Proposed Contractor(s) and Address:

__ Abbott Molecular Inc. _________________ __1300 E Touhy Ave_______________________ __Des Plaines IL, 60018___________________

Brand Name Buy: No

3. Description of Services or Supplies: This requirement includes full maintenance services for the government owned Abbott m2000sp/rt System. The work required under this contract shall include: (1) Planned Preventative Maintenance Service; (2) Emergency Repair Service; and (3) Technical Support Service.

Base Period: 30 September 2019 to 29 September 2020 Value: $16,821.16 Option Period 1: 30 September 2020 to 29 September 2021 Value: $16,821.16 Option Period 2: 30 September 2021 to 29 September 2022 Value: $16,821.16 Option Period 3: 30 September 2022 to 29 September 2023 Value: $16,821.16 Option Period 4: 30 September 2023 to 29 September 2024 Value: $16,821.16 FAR Clause 52.217-8 Option: 30 September 2024 to 29 March 2025 Value: $ 8,410.58

Total: $92,516.36

4. Authority:

FAR 13.106-1(b)(1): For purchases not exceeding the simplified acquisition threshold (SAT), only one source reasonably available, urgency, exclusive licensing agreements, brand name, or industrial mobilization.

5. Reasons for Authority Cited: Abbott Molecular is the equipment manufacture of m2000sp/rt. The Abbott m2000sp/rt System arrived at WRAIR in October 2018 and is 510K cleared for clinical testing. The equipment must be functional and operational according to the manufacturer design specifications for its usage. Preventive maintenance, technical support and emergency repair service contract is required to maintain the performance functionality of the equipment. The maintenance services required can only be performed by the original equipment manufacturer. Abbott Molecular, Inc has not granted any other third parties with a license to service its instrumentation. Due to the proprietary nature of this requirement, only Abbott Molecular, Inc. can meet the Government’s need.

6. Publicizing Contract Actions: For FAR Part 13 actions, the public display and synopsis requirements of FAR 5.101 and FAR 5.203 apply and will be followed.

7. Market Research: A Request for Information (RFI) was posted on Federal Business Opportunities (FBO) from 15 August 2019 – 22 August 2019. Potential sources were given the opportunity to provide capability statements. One vendor submitted a capability statement, the Abbott Molecular, Inc. The Government’s subject matter expert conducted a review of the capability statement and the Abbott Molecular, Inc. has provided sufficient information to demonstrate their ability to pvide preventative maintenance for the Abbott m2000sp/rt System.

A Notice of Intent to sole source to Abbott Molecular, Inc. was posted on FBO on 22 August 2019 for 15 days. As a result of the intent, no responses were received.

This market research revealed that Abbott is the only vendor that can provide services and consumables for the Abbott m2000sp/rt System, due to the fact that it has not licensed the right to sell or maintain its products to any other vendor.

8. Other Facts: Not applicable

9. Technical/Requirements Certification: I certify that the supporting data under my cognizance which are included in the justification are accurate and complete to the best of my knowledge and belief.

Typed Name: Dr. Linda Jagodzinski Date:

Title:

Signature:

10. Contracting Officer Certification/Approval: I hereby determine that the anticipated cost or price to the Government for this contract action will be fair and reasonable based upon a price analysis.

I certify that this justification is accurate and complete to the best of my knowledge and belief, and that completing this purchase as a sole source is in the best interest of the Government. Additionally, I approve this justification to limit competition subject to the availability of funds and provided that the services or supplies herein described have otherwise been authorized for acquisition.

Typed Name: Jennifer C. Jackson Date:

Title: Contracting Officer Signature: